# Pymaceuticals-Inc.
Pymaceuticals, Inc. is a new pharmaceutical company that specializes in anti-cancer medications. Recently, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer. This new study shows the results of 249 mice who were identified with SCC tumors and received treatment with a range of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.
